Search Results - "Kojda, G"

Refine Results
  1. 1

    Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? by KOJDA, Georg, HAMBRECHT, Rainer

    Published in Cardiovascular research (01-08-2005)
    “…A lack of exercise training and/or regular physical activity is a known risk factor for cardiovascular disease. Exercise training induces marked vascular…”
    Get full text
    Journal Article
  2. 2

    Nonallergic angioedema: role of bradykinin by Bas, M, Adams, V, Suvorava, T, Niehues, T, Hoffmann, T.K, Kojda, G

    Published in Allergy (01-08-2007)
    “…Angioedema is an underestimated clinical problem. Many cases are nonallergic reactions, e.g. bradykinin-induced angioedema caused by genetic defects and…”
    Get full text
    Journal Article
  3. 3

    Angioedema induced by cardiovascular drugs: new players join old friends by Bas, M., Greve, J., Strassen, U., Khosravani, F., Hoffmann, T. K., Kojda, G.

    Published in Allergy (Copenhagen) (01-10-2015)
    “…During the last years, two new cardiovascular drug classes, namely inhibitors of DPP IV or neprilysin, have been developed. In both cases, there is clinical…”
    Get full text
    Journal Article
  4. 4

    New topics in bradykinin research by Maurer, M., Bader, M., Bas, M., Bossi, F., Cicardi, M., Cugno, M., Howarth, P., Kaplan, A., Kojda, G., Leeb‐Lundberg, F., Lötvall, J., Magerl, M.

    Published in Allergy (Copenhagen) (01-11-2011)
    “…To cite this article: Maurer M, Bader M, Bas M, Bossi F, Cicardi M, Cugno M, Howarth P, Kaplan A, Kojda G, Leeb‐Lundberg F, Lötvall J, Magerl M. New topics in…”
    Get full text
    Journal Article
  5. 5

    Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction by Fehsel, K, Schwanke, K, Kappel, BA, Fahimi, E, Meisenzahl-Lechner, E, Esser, C, Hemmrich, K, Haarmann-Stemmann, T, Kojda, G, Lange-Asschenfeldt, C

    Published in Journal of psychopharmacology (Oxford) (01-02-2022)
    “…Background: The superior therapeutic benefit of clozapine is often associated with metabolic disruptions as obesity, insulin resistance, tachycardia, higher…”
    Get full text
    Journal Article
  6. 6

    Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1‐INH by Khosravani, F., Suvorava, T., Dao, V. T.‐V., Brockmann, N., Kocgirli, O., Herbst, F. F., Valcaccia, S., Kassack, M. U., Bas, M., Kojda, G.

    Published in Allergy (Copenhagen) (01-03-2015)
    “…Background Little is known about factors which trigger and/or contribute to hereditary angioedema or ACE‐inhibitor‐mediated angioedema including variations in…”
    Get full text
    Journal Article
  7. 7

    Increased C‐reactive protein in ACE‐inhibitor‐induced angioedema by Bas, M., Hoffmann, T. K., Bier, H., Kojda, G.

    Published in British journal of clinical pharmacology (01-02-2005)
    “…Aims This study was designed to identify new factors which may contribute to angiotensin‐converting‐enzyme‐inhibitor (ACEI)‐induced angioedema. Methods In a…”
    Get full text
    Journal Article
  8. 8

    Bradycardic effect of endothelial-specific bradykinin type-II receptors overexpression in mice: impact on blood pressure by Metry, S, Suvorava, T, Kojda, G

    Published in European heart journal (09-11-2023)
    “…Abstract Background/Introduction Polymorphisms of the gene encoding for the bradykinin type-II receptors (B2R) has been shown to decrease the expression of B2R…”
    Get full text
    Journal Article
  9. 9

    Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase by Oppermann, M, Dao, V T‐V, Suvorava, T, Bas, M, Kojda, G

    Published in British journal of pharmacology (01-10-2008)
    “…Background and purpose: The regulation of vascular soluble guanylyl cyclase (sGC) expression by nitric oxide (NO) is still under discussion. In vitro, NO has…”
    Get full text
    Journal Article
  10. 10

    Organic nitrates in cardiovascular disease by Bode-Böger, S M, Kojda, G

    “…Therapeutic activation of the vascular NO/cGMP pathway is induced by a variety of stimuli/mediators including physical activity, supplementation with the…”
    Get more information
    Journal Article
  11. 11

    Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy by Morawietz, H., Rohrbach, S., Rueckschloss, U., Schellenberger, E., Hakim, K., Zerkowski, H.-R., Kojda, G., Darmer, D., Holtz, J.

    Published in European journal of clinical investigation (01-10-2006)
    “…Background  The efficacy of angiotensin‐converting enzyme (ACE) inhibitors has been demonstrated in large clinical trials, but knowledge of the underlying…”
    Get full text
    Journal Article
  12. 12

    ACE-inhibitor induced angioedema by Bas, M, Hoffmann, T K, Kojda, G, Bier, H

    Published in Laryngo- rhino- otologie (01-11-2007)
    “…ACE-inhibitor induced angioedema is a non-allergic drug-related side effect. Inhibited bradykinin degradation leads to an unphysiological enhanced bradykinin…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Impaired vasodilator response to organic nitrates in isolated basilar arteries by Martens, Dorothee, Kojda, Georg

    Published in British journal of pharmacology (01-01-2001)
    “…The differential responsiveness of various sections and regions in the vascular system to the vasodilator activity of organic nitrates is important for the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure by Kojda, G, Harrison, D

    Published in Cardiovascular research (15-08-1999)
    “…There is a growing body of evidence suggesting that numerous pathological conditions are associated with increased vascular production of reactive oxygen…”
    Get full text
    Journal Article
  18. 18

    The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits by Müllenheim, J, Müller, S, Laber, U, Thämer, V, Meyer, W, Bassenge, E, Fink, B, Kojda, G

    “…Experimental studies with therapeutic doses of pentaerythritol tetranitrate (PETN) have shown unexpected actions such as a lack of nitrate tolerance and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Vasoprotection by nitric oxide: mechanisms and therapeutic potential by GEWALTIG, Michael T, KOJDA, Georg

    Published in Cardiovascular research (01-08-2002)
    “…Endothelial production of nitric oxide (nitrogen monoxide, NO) has become a major research area in vascular biology. Some of the most important effects that NO…”
    Get full text
    Journal Article